{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T03:33:37Z","timestamp":1771644817035,"version":"3.50.1"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T00:00:00Z","timestamp":1722384000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Oligomeric alpha-synuclein in red blood cells (RBC-o-\u03b1-Syn) has been shown to be increased in patients with Parkinson\u2019s disease (PD). However, factors that affect RBC-o-\u03b1-Syn levels remain to be elucidated. The aim of this study is to analyze the correlations between RBC-o-\u03b1-Syn levels and the age, sex and different clinical variables of patients with PD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>167 patients with PD and 119 healthy controls (HC) were enrolled in this study. The patients with PD were diagnosed based on the MDS clinical diagnostic criteria for PD. All participants were evaluated for their clinical characteristics. Western blot analysis was used to examine the molecular sizes of RBC-o-\u03b1-Syn. A newly established chemiluminescent immunoassay was used to measure RBC-o-\u03b1-Syn levels.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Higher RBC-o-\u03b1-Syn levels were detected in PD patients than in HC subjects. The receiver operating characteristic (ROC) curve indicated that a cut off value of 55.29 ng\/mg discriminated well between PD patients and HC subjects, with a sensitivity of 67.66% (95% CI: 60.24\u201374.29%), a specificity of 88.24% (95% CI: 81.22\u201392.86%), and an area under the curve (AUC) of 0.857. The levels of RBC-o-\u03b1-Syn were higher in female than male patients (<jats:italic>p<\/jats:italic> =\u20090.033). For different subtypes, the levels of RBC-o-\u03b1-Syn were higher in the MIX subtype than the tremor-dominant (TD) PD. In addition, the levels of RBC-o-\u03b1-Syn were higher in patients with than without cognitive impairment (<jats:italic>p<\/jats:italic> =\u20090.016), and negatively correlated with Mini-Mental State Examination (MMSE) scores (<jats:italic>r<\/jats:italic> =\u2009\u22120.156, <jats:italic>p<\/jats:italic> =\u20090.044).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our study demonstrates that RBC-o-\u03b1-Syn levels in patients with PD are higher than those in HC subjects and affected by the sex and the severity of cognitive impairment.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fnagi.2024.1437622","type":"journal-article","created":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T05:15:17Z","timestamp":1722402917000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Correlations of erythrocytic oligomer \u03b1-synuclein levels with age, sex and clinical variables in patients with Parkinson\u2019s disease"],"prefix":"10.3389","volume":"16","author":[{"given":"Zhe","family":"Lu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengjie","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeyun","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaodong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,7,31]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1001\/archneur.1996.00550060082020","article-title":"Frequency of dementia in Parkinson disease","volume":"53","author":"Aarsland","year":"1996","journal-title":"Arch. Neurol."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1159\/000112832","article-title":"Red blood cells are the major source of alpha-synuclein in blood","volume":"5","author":"Barbour","year":"2008","journal-title":"Neurodegener Dis"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s00401-017-1755-1","article-title":"Alpha-synuclein oligomers: a new hope","volume":"134","author":"Bengoa-Vergniory","year":"2017","journal-title":"Acta Neuropathol."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"5221","DOI":"10.1523\/JNEUROSCI.4650-14.2015","article-title":"Definition of a molecular pathway mediating alpha-synuclein neurotoxicity","volume":"35","author":"Burre","year":"2015","journal-title":"J. Neurosci."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1146\/annurev.neuro.26.010302.081142","article-title":"Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders","volume":"26","author":"Caughey","year":"2003","journal-title":"Annu. Rev. Neurosci."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3233\/JPD-191683","article-title":"Parkinson's disease in women and men: What's the difference?","volume":"9","author":"Cerri","year":"2019","journal-title":"J. Parkinsons Dis."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"8466","DOI":"10.18632\/oncotarget.6445","article-title":"Age-and brain region-dependent alpha-synuclein oligomerization is attributed to alterations in intrinsic enzymes regulating alpha-synuclein phosphorylation in aging monkey brains","volume":"7","author":"Chen","year":"2016","journal-title":"Oncotarget"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"e48","DOI":"10.1212\/WNL.0000000000004764","article-title":"Sex disparities in access to caregiving in Parkinson disease","volume":"90","author":"Dahodwala","year":"2018","journal-title":"Neurology"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3389\/fnmol.2018.00053","article-title":"Alpha-Synuclein Heterocomplexes with beta-amyloid are increased in red blood cells of Parkinson's disease patients and correlate with disease severity","volume":"11","author":"Daniele","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","article-title":"Epidemiology of Parkinson's disease","volume":"5","author":"de Lau","year":"2006","journal-title":"Lancet Neurol."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"e011113","DOI":"10.1136\/bmjopen-2016-011113","article-title":"Diagnostic utility of CSF alpha-synuclein species in Parkinson's disease: protocol for a systematic review and meta-analysis","volume":"6","author":"Eusebi","year":"2016","journal-title":"BMJ Open"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1111\/jnc.14809","article-title":"Parkinson's disease biomarkers based on alpha-synuclein","volume":"150","author":"Fayyad","year":"2019","journal-title":"J. Neurochem."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"702639","DOI":"10.3389\/fnagi.2021.702639","article-title":"Alpha-Synuclein as a biomarker of Parkinson's disease: good, but not good enough","volume":"13","author":"Ganguly","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1002\/mds.21956","article-title":"The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years","volume":"23","author":"Hely","year":"2008","journal-title":"Mov. Disord."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1080\/15548627.2019.1603545","article-title":"Age-dependent accumulation of oligomeric SNCA\/alpha-synuclein from impaired degradation in mutant LRRK2 knockin mouse model of Parkinson disease: role for therapeutic activation of chaperone-mediated autophagy (CMA)","volume":"16","author":"Ho","year":"2020","journal-title":"Autophagy"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1093\/brain\/awq008","article-title":"DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease","volume":"133","author":"Hong","year":"2010","journal-title":"Brain"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","article-title":"Parkinson's disease: clinical features and diagnosis","volume":"79","author":"Jankovic","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1002\/mds.25070","article-title":"Changes on brief cognitive instruments over time in Parkinson's disease","volume":"27","author":"Lessig","year":"2012","journal-title":"Mov. Disord."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"899892","DOI":"10.3389\/fnagi.2022.899892","article-title":"Receptor-dependent endocytosis mediates alpha-Synuclein oligomer transport into red blood cells","volume":"14","author":"Li","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"134640","DOI":"10.1016\/j.neulet.2019.134640","article-title":"Alpha-synuclein oligomerization and dopaminergic degeneration occur synchronously in the brain and colon of MPTP-intoxicated parkinsonian monkeys","volume":"716","author":"Li","year":"2020","journal-title":"Neurosci. Lett."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/mds.24893","article-title":"Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society task force guidelines","volume":"27","author":"Litvan","year":"2012","journal-title":"Mov. Disord."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.parkreldis.2022.09.011","article-title":"Erythrocytic alpha-synuclein in early Parkinson's disease: a 3-year longitudinal study","volume":"104","author":"Liu","year":"2022","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1056\/NEJM2003ra020003","article-title":"Alzheimer's disease and Parkinson's disease","volume":"348","author":"Nussbaum","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3389\/fnagi.2014.00053","article-title":"Differential role of CSF alpha-synuclein species, tau, and Abeta42 in Parkinson's disease","volume":"6","author":"Parnetti","year":"2014","journal-title":"Front. Aging Neurosci."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S1474-4422(19)30024-9","article-title":"CSF and blood biomarkers for Parkinson's disease","volume":"18","author":"Parnetti","year":"2019","journal-title":"Lancet Neurol."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1212\/WNL.0000000000001621","article-title":"How much does sex matter in Parkinson disease?","volume":"84","author":"Picillo","year":"2015","journal-title":"Neurology"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson's disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nrn.2017.62","article-title":"Non-motor features of Parkinson disease","volume":"18","author":"Schapira","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1002\/mds.25383","article-title":"How to identify tremor dominant and postural instability\/gait difficulty groups with the movement disorder society unified Parkinson's disease rating scale: comparison with the unified Parkinson's disease rating scale","volume":"28","author":"Stebbins","year":"2013","journal-title":"Mov. Disord."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.peptides.2014.09.018","article-title":"Alpha synuclein is transported into and out of the brain by the blood-brain barrier","volume":"62","author":"Sui","year":"2014","journal-title":"Peptides"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s40035-019-0155-y","article-title":"Erythrocytic alpha-Synuclein as a potential biomarker for Parkinson's disease","volume":"8","author":"Tian","year":"2019","journal-title":"Transl. Neurodegener."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"173862","DOI":"10.1016\/j.ejphar.2021.173862","article-title":"Parkinson's disease in women: mechanisms underlying sex differences","volume":"895","author":"Vaidya","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"e0151156","DOI":"10.1371\/journal.pone.0151156","article-title":"Abnormal salivary Total and oligomeric alpha-Synuclein in Parkinson's disease","volume":"11","author":"Vivacqua","year":"2016","journal-title":"PLoS One"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.neulet.2015.05.030","article-title":"Detection of alpha-synuclein oligomers in red blood cells as a potential biomarker of Parkinson's disease","volume":"599","author":"Wang","year":"2015","journal-title":"Neurosci. Lett."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1136\/jnnp.2003.020982","article-title":"Are men at greater risk for Parkinson's disease than women?","volume":"75","author":"Wooten","year":"2004","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.3233\/JPD-212694","article-title":"Comparison of different platform immunoassays for the measurement of plasma alpha-Synuclein in Parkinson's disease patients","volume":"11","author":"Youssef","year":"2021","journal-title":"J. Parkinsons Dis."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"827493","DOI":"10.3389\/fnagi.2022.827493","article-title":"Erythrocytic alpha-Synuclein species for Parkinson's disease diagnosis and the correlations with clinical characteristics","volume":"14","author":"Yu","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1173074","DOI":"10.3389\/fneur.2023.1173074","article-title":"Erythrocytic alpha-synuclein as potential biomarker for the differentiation between essential tremor and Parkinson's disease","volume":"14","author":"Yu","year":"2023","journal-title":"Front. Neurol."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.parkreldis.2022.06.001","article-title":"Plasma and serum alpha-synuclein as a biomarker in Parkinson's disease: a meta-analysis","volume":"99","author":"Zubelzu","year":"2022","journal-title":"Parkinsonism Relat. Disord."}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2024.1437622\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T05:15:22Z","timestamp":1722402922000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2024.1437622\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,31]]},"references-count":39,"alternative-id":["10.3389\/fnagi.2024.1437622"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2024.1437622","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,31]]},"article-number":"1437622"}}